1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Influenza Diagnostics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 RIDT 1.2.3 RT-PCR 1.2.4 Cell Culture 1.2.5 Others 1.3 Market by Application 1.3.1 Global Influenza Diagnostics Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospitals 1.3.3 POCT 1.3.4 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Influenza Diagnostics Market Perspective (2016-2027) 2.2 Influenza Diagnostics Growth Trends by Regions 2.2.1 Influenza Diagnostics Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Influenza Diagnostics Historic Market Share by Regions (2016-2021) 2.2.3 Influenza Diagnostics Forecasted Market Size by Regions (2022-2027) 2.3 Influenza Diagnostics Industry Dynamic 2.3.1 Influenza Diagnostics Market Trends 2.3.2 Influenza Diagnostics Market Drivers 2.3.3 Influenza Diagnostics Market Challenges 2.3.4 Influenza Diagnostics Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Influenza Diagnostics Players by Revenue 3.1.1 Global Top Influenza Diagnostics Players by Revenue (2016-2021) 3.1.2 Global Influenza Diagnostics Revenue Market Share by Players (2016-2021) 3.2 Global Influenza Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Influenza Diagnostics Revenue 3.4 Global Influenza Diagnostics Market Concentration Ratio 3.4.1 Global Influenza Diagnostics Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Influenza Diagnostics Revenue in 2020 3.5 Influenza Diagnostics Key Players Head office and Area Served 3.6 Key Players Influenza Diagnostics Product Solution and Service 3.7 Date of Enter into Influenza Diagnostics Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Influenza Diagnostics Breakdown Data by Type 4.1 Global Influenza Diagnostics Historic Market Size by Type (2016-2021) 4.2 Global Influenza Diagnostics Forecasted Market Size by Type (2022-2027) 5 Influenza Diagnostics Breakdown Data by Application 5.1 Global Influenza Diagnostics Historic Market Size by Application (2016-2021) 5.2 Global Influenza Diagnostics Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Influenza Diagnostics Market Size (2016-2027) 6.2 North America Influenza Diagnostics Market Size by Type 6.2.1 North America Influenza Diagnostics Market Size by Type (2016-2021) 6.2.2 North America Influenza Diagnostics Market Size by Type (2022-2027) 6.2.3 North America Influenza Diagnostics Market Size by Type (2016-2027) 6.3 North America Influenza Diagnostics Market Size by Application 6.3.1 North America Influenza Diagnostics Market Size by Application (2016-2021) 6.3.2 North America Influenza Diagnostics Market Size by Application (2022-2027) 6.3.3 North America Influenza Diagnostics Market Size by Application (2016-2027) 6.4 North America Influenza Diagnostics Market Size by Country 6.4.1 North America Influenza Diagnostics Market Size by Country (2016-2021) 6.4.2 North America Influenza Diagnostics Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Influenza Diagnostics Market Size (2016-2027) 7.2 Europe Influenza Diagnostics Market Size by Type 7.2.1 Europe Influenza Diagnostics Market Size by Type (2016-2021) 7.2.2 Europe Influenza Diagnostics Market Size by Type (2022-2027) 7.2.3 Europe Influenza Diagnostics Market Size by Type (2016-2027) 7.3 Europe Influenza Diagnostics Market Size by Application 7.3.1 Europe Influenza Diagnostics Market Size by Application (2016-2021) 7.3.2 Europe Influenza Diagnostics Market Size by Application (2022-2027) 7.3.3 Europe Influenza Diagnostics Market Size by Application (2016-2027) 7.4 Europe Influenza Diagnostics Market Size by Country 7.4.1 Europe Influenza Diagnostics Market Size by Country (2016-2021) 7.4.2 Europe Influenza Diagnostics Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Influenza Diagnostics Market Size (2016-2027) 8.2 Asia-Pacific Influenza Diagnostics Market Size by Type 8.2.1 Asia-Pacific Influenza Diagnostics Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Influenza Diagnostics Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Influenza Diagnostics Market Size by Type (2016-2027) 8.3 Asia-Pacific Influenza Diagnostics Market Size by Application 8.3.1 Asia-Pacific Influenza Diagnostics Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Influenza Diagnostics Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Influenza Diagnostics Market Size by Application (2016-2027) 8.4 Asia-Pacific Influenza Diagnostics Market Size by Region 8.4.1 Asia-Pacific Influenza Diagnostics Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Influenza Diagnostics Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Influenza Diagnostics Market Size (2016-2027) 9.2 Latin America Influenza Diagnostics Market Size by Type 9.2.1 Latin America Influenza Diagnostics Market Size by Type (2016-2021) 9.2.2 Latin America Influenza Diagnostics Market Size by Type (2022-2027) 9.2.3 Latin America Influenza Diagnostics Market Size by Type (2016-2027) 9.3 Latin America Influenza Diagnostics Market Size by Application 9.3.1 Latin America Influenza Diagnostics Market Size by Application (2016-2021) 9.3.2 Latin America Influenza Diagnostics Market Size by Application (2022-2027) 9.3.3 Latin America Influenza Diagnostics Market Size by Application (2016-2027) 9.4 Latin America Influenza Diagnostics Market Size by Country 9.4.1 Latin America Influenza Diagnostics Market Size by Country (2016-2021) 9.4.2 Latin America Influenza Diagnostics Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Influenza Diagnostics Market Size (2016-2027) 10.2 Middle East & Africa Influenza Diagnostics Market Size by Type 10.2.1 Middle East & Africa Influenza Diagnostics Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Influenza Diagnostics Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Influenza Diagnostics Market Size by Type (2016-2027) 10.3 Middle East & Africa Influenza Diagnostics Market Size by Application 10.3.1 Middle East & Africa Influenza Diagnostics Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Influenza Diagnostics Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Influenza Diagnostics Market Size by Application (2016-2027) 10.4 Middle East & Africa Influenza Diagnostics Market Size by Country 10.4.1 Middle East & Africa Influenza Diagnostics Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Influenza Diagnostics Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 BD 11.1.1 BD Company Details 11.1.2 BD Business Overview 11.1.3 BD Influenza Diagnostics Introduction 11.1.4 BD Revenue in Influenza Diagnostics Business (2016-2021) 11.1.5 BD Recent Development 11.2 Abbott (Include Alere) 11.2.1 Abbott (Include Alere) Company Details 11.2.2 Abbott (Include Alere) Business Overview 11.2.3 Abbott (Include Alere) Influenza Diagnostics Introduction 11.2.4 Abbott (Include Alere) Revenue in Influenza Diagnostics Business (2016-2021) 11.2.5 Abbott (Include Alere) Recent Development 11.3 Roche 11.3.1 Roche Company Details 11.3.2 Roche Business Overview 11.3.3 Roche Influenza Diagnostics Introduction 11.3.4 Roche Revenue in Influenza Diagnostics Business (2016-2021) 11.3.5 Roche Recent Development 11.4 SIEMENS 11.4.1 SIEMENS Company Details 11.4.2 SIEMENS Business Overview 11.4.3 SIEMENS Influenza Diagnostics Introduction 11.4.4 SIEMENS Revenue in Influenza Diagnostics Business (2016-2021) 11.4.5 SIEMENS Recent Development 11.5 Analytik Jena 11.5.1 Analytik Jena Company Details 11.5.2 Analytik Jena Business Overview 11.5.3 Analytik Jena Influenza Diagnostics Introduction 11.5.4 Analytik Jena Revenue in Influenza Diagnostics Business (2016-2021) 11.5.5 Analytik Jena Recent Development 11.6 Quidel 11.6.1 Quidel Company Details 11.6.2 Quidel Business Overview 11.6.3 Quidel Influenza Diagnostics Introduction 11.6.4 Quidel Revenue in Influenza Diagnostics Business (2016-2021) 11.6.5 Quidel Recent Development 11.7 Thermo Fisher 11.7.1 Thermo Fisher Company Details 11.7.2 Thermo Fisher Business Overview 11.7.3 Thermo Fisher Influenza Diagnostics Introduction 11.7.4 Thermo Fisher Revenue in Influenza Diagnostics Business (2016-2021) 11.7.5 Thermo Fisher Recent Development 11.8 Meridian Bioscience 11.8.1 Meridian Bioscience Company Details 11.8.2 Meridian Bioscience Business Overview 11.8.3 Meridian Bioscience Influenza Diagnostics Introduction 11.8.4 Meridian Bioscience Revenue in Influenza Diagnostics Business (2016-2021) 11.8.5 Meridian Bioscience Recent Development 11.9 BioMerieux 11.9.1 BioMerieux Company Details 11.9.2 BioMerieux Business Overview 11.9.3 BioMerieux Influenza Diagnostics Introduction 11.9.4 BioMerieux Revenue in Influenza Diagnostics Business (2016-2021) 11.9.5 BioMerieux Recent Development 11.10 Sekisui Diagnostics 11.10.1 Sekisui Diagnostics Company Details 11.10.2 Sekisui Diagnostics Business Overview 11.10.3 Sekisui Diagnostics Influenza Diagnostics Introduction 11.10.4 Sekisui Diagnostics Revenue in Influenza Diagnostics Business (2016-2021) 11.10.5 Sekisui Diagnostics Recent Development 11.11 Response Biomedical 11.11.1 Response Biomedical Company Details 11.11.2 Response Biomedical Business Overview 11.11.3 Response Biomedical Influenza Diagnostics Introduction 11.11.4 Response Biomedical Revenue in Influenza Diagnostics Business (2016-2021) 11.11.5 Response Biomedical Recent Development 11.12 SA Scientific 11.12.1 SA Scientific Company Details 11.12.2 SA Scientific Business Overview 11.12.3 SA Scientific Influenza Diagnostics Introduction 11.12.4 SA Scientific Revenue in Influenza Diagnostics Business (2016-2021) 11.12.5 SA Scientific Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Influenza Diagnostics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of RIDT Table 3. Key Players of RT-PCR Table 4. Key Players of Cell Culture Table 5. Key Players of Others Table 6. Global Influenza Diagnostics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global Influenza Diagnostics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 8. Global Influenza Diagnostics Market Size by Regions (2016-2021) & (US$ Million) Table 9. Global Influenza Diagnostics Market Share by Regions (2016-2021) Table 10. Global Influenza Diagnostics Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 11. Global Influenza Diagnostics Market Share by Regions (2022-2027) Table 12. Influenza Diagnostics Market Trends Table 13. Influenza Diagnostics Market Drivers Table 14. Influenza Diagnostics Market Challenges Table 15. Influenza Diagnostics Market Restraints Table 16. Global Influenza Diagnostics Revenue by Players (2016-2021) & (US$ Million) Table 17. Global Influenza Diagnostics Market Share by Players (2016-2021) Table 18. Global Top Influenza Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Influenza Diagnostics as of 2020) Table 19. Ranking of Global Top Influenza Diagnostics Companies by Revenue (US$ Million) in 2020 Table 20. Global 5 Largest Players Market Share by Influenza Diagnostics Revenue (CR5 and HHI) & (2016-2021) Table 21. Key Players Headquarters and Area Served Table 22. Key Players Influenza Diagnostics Product Solution and Service Table 23. Date of Enter into Influenza Diagnostics Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global Influenza Diagnostics Market Size by Type (2016-2021) (US$ Million) Table 26. Global Influenza Diagnostics Revenue Market Share by Type (2016-2021) Table 27. Global Influenza Diagnostics Forecasted Market Size by Type (2022-2027) (US$ Million) Table 28. Global Influenza Diagnostics Revenue Market Share by Type (2022-2027) & (US$ Million) Table 29. Global Influenza Diagnostics Market Size Share by Application (2016-2021) & (US$ Million) Table 30. Global Influenza Diagnostics Revenue Market Share by Application (2016-2021) Table 31. Global Influenza Diagnostics Forecasted Market Size by Application (2022-2027) (US$ Million) Table 32. Global Influenza Diagnostics Revenue Market Share by Application (2022-2027) & (US$ Million) Table 33. North America Influenza Diagnostics Market Size by Type (2016-2021) (US$ Million) Table 34. North America Influenza Diagnostics Market Size by Type (2022-2027) & (US$ Million) Table 35. North America Influenza Diagnostics Market Size by Application (2016-2021) (US$ Million) Table 36. North America Influenza Diagnostics Market Size by Application (2022-2027) & (US$ Million) Table 37. North America Influenza Diagnostics Market Size by Country (2016-2021) & (US$ Million) Table 38. North America Influenza Diagnostics Market Size by Country (2022-2027) & (US$ Million) Table 39. Europe Influenza Diagnostics Market Size by Type (2016-2021) (US$ Million) Table 40. Europe Influenza Diagnostics Market Size by Type (2022-2027) & (US$ Million) Table 41. Europe Influenza Diagnostics Market Size by Application (2016-2021) (US$ Million) Table 42. Europe Influenza Diagnostics Market Size by Application (2022-2027) & (US$ Million) Table 43. Europe Influenza Diagnostics Market Size by Country (2016-2021) & (US$ Million) Table 44. Europe Influenza Diagnostics Market Size by Country (2022-2027) & (US$ Million) Table 45. Asia-Pacific Influenza Diagnostics Market Size by Type (2016-2021) (US$ Million) Table 46. Asia-Pacific Influenza Diagnostics Market Size by Type (2022-2027) & (US$ Million) Table 47. Asia-Pacific Influenza Diagnostics Market Size by Application (2016-2021) (US$ Million) Table 48. Asia-Pacific Influenza Diagnostics Market Size by Application (2022-2027) & (US$ Million) Table 49. Asia-Pacific Influenza Diagnostics Market Size by Region (2016-2021) & (US$ Million) Table 50. Asia-Pacific Influenza Diagnostics Market Size by Region (2022-2027) & (US$ Million) Table 51. Latin America Influenza Diagnostics Market Size by Type (2016-2021) (US$ Million) Table 52. Latin America Influenza Diagnostics Market Size by Type (2022-2027) & (US$ Million) Table 53. Latin America Influenza Diagnostics Market Size by Application (2016-2021) (US$ Million) Table 54. Latin America Influenza Diagnostics Market Size by Application (2022-2027) & (US$ Million) Table 55. Latin America Influenza Diagnostics Market Size by Country (2016-2021) & (US$ Million) Table 56. Latin America Influenza Diagnostics Market Size by Country (2022-2027) & (US$ Million) Table 57. Middle East & Africa Influenza Diagnostics Market Size by Type (2016-2021) (US$ Million) Table 58. Middle East & Africa Influenza Diagnostics Market Size by Type (2022-2027) & (US$ Million) Table 59. Middle East & Africa Influenza Diagnostics Market Size by Application (2016-2021) (US$ Million) Table 60. Middle East & Africa Influenza Diagnostics Market Size by Application (2022-2027) & (US$ Million) Table 61. Middle East & Africa Influenza Diagnostics Market Size by Country (2016-2021) & (US$ Million) Table 62. Middle East & Africa Influenza Diagnostics Market Size by Country (2022-2027) & (US$ Million) Table 63. BD Company Details Table 64. BD Business Overview Table 65. BD Influenza Diagnostics Product Table 66. BD Revenue in Influenza Diagnostics Business (2016-2021) & (US$ Million) Table 67. BD Recent Development Table 68. Abbott (Include Alere) Company Details Table 69. Abbott (Include Alere) Business Overview Table 70. Abbott (Include Alere) Influenza Diagnostics Product Table 71. Abbott (Include Alere) Revenue in Influenza Diagnostics Business (2016-2021) & (US$ Million) Table 72. Abbott (Include Alere) Recent Development Table 73. Roche Company Details Table 74. Roche Business Overview Table 75. Roche Influenza Diagnostics Product Table 76. Roche Revenue in Influenza Diagnostics Business (2016-2021) & (US$ Million) Table 77. Roche Recent Development Table 78. SIEMENS Company Details Table 79. SIEMENS Business Overview Table 80. SIEMENS Influenza Diagnostics Product Table 81. SIEMENS Revenue in Influenza Diagnostics Business (2016-2021) & (US$ Million) Table 82. SIEMENS Recent Development Table 83. Analytik Jena Company Details Table 84. Analytik Jena Business Overview Table 85. Analytik Jena Influenza Diagnostics Product Table 86. Analytik Jena Revenue in Influenza Diagnostics Business (2016-2021) & (US$ Million) Table 87. Analytik Jena Recent Development Table 88. Quidel Company Details Table 89. Quidel Business Overview Table 90. Quidel Influenza Diagnostics Product Table 91. Quidel Revenue in Influenza Diagnostics Business (2016-2021) & (US$ Million) Table 92. Quidel Recent Development Table 93. Thermo Fisher Company Details Table 94. Thermo Fisher Business Overview Table 95. Thermo Fisher Influenza Diagnostics Product Table 96. Thermo Fisher Revenue in Influenza Diagnostics Business (2016-2021) & (US$ Million) Table 97. Thermo Fisher Recent Development Table 98. Meridian Bioscience Company Details Table 99. Meridian Bioscience Business Overview Table 100. Meridian Bioscience Revenue in Influenza Diagnostics Business (2016-2021) & (US$ Million) Table 101. Meridian Bioscience Recent Development Table 102. BioMerieux Company Details Table 103. BioMerieux Business Overview Table 104. BioMerieux Influenza Diagnostics Product Table 105. BioMerieux Revenue in Influenza Diagnostics Business (2016-2021) & (US$ Million) Table 106. BioMerieux Recent Development Table 107. Sekisui Diagnostics Company Details Table 108. Sekisui Diagnostics Business Overview Table 109. Sekisui Diagnostics Influenza Diagnostics Product Table 110. Sekisui Diagnostics Revenue in Influenza Diagnostics Business (2016-2021) & (US$ Million) Table 111. Sekisui Diagnostics Recent Development Table 112. Response Biomedical Company Details Table 113. Response Biomedical Business Overview Table 114. Response Biomedical Influenza Diagnostics Product Table 115. Response Biomedical Revenue in Influenza Diagnostics Business (2016-2021) & (US$ Million) Table 116. Response Biomedical Recent Development Table 117. SA Scientific Company Details Table 118. SA Scientific Business Overview Table 119. SA Scientific Influenza Diagnostics Product Table 120. SA Scientific Revenue in Influenza Diagnostics Business (2016-2021) & (US$ Million) Table 121. SA Scientific Recent Development Table 122. Research Programs/Design for This Report Table 123. Key Data Information from Secondary Sources Table 124. Key Data Information from Primary Sources List of Figures Figure 1. Global Influenza Diagnostics Market Share by Type: 2020 VS 2027 Figure 2. RIDT Features Figure 3. RT-PCR Features Figure 4. Cell Culture Features Figure 5. Others Features Figure 6. Global Influenza Diagnostics Market Share by Application: 2020 VS 2027 Figure 7. Hospitals Case Studies Figure 8. POCT Case Studies Figure 9. Others Case Studies Figure 10. Influenza Diagnostics Report Years Considered Figure 11. Global Influenza Diagnostics Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 12. Global Influenza Diagnostics Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 13. Global Influenza Diagnostics Market Share by Regions: 2020 VS 2027 Figure 14. Global Influenza Diagnostics Market Share by Regions (2022-2027) Figure 15. Global Influenza Diagnostics Market Share by Players in 2020 Figure 16. Global Top Influenza Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Influenza Diagnostics as of 2020 Figure 17. The Top 10 and 5 Players Market Share by Influenza Diagnostics Revenue in 2020 Figure 18. Global Influenza Diagnostics Revenue Market Share by Type (2016-2021) Figure 19. Global Influenza Diagnostics Revenue Market Share by Type (2022-2027) Figure 20. North America Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 21. North America Influenza Diagnostics Market Share by Type (2016-2027) Figure 22. North America Influenza Diagnostics Market Share by Application (2016-2027) Figure 23. North America Influenza Diagnostics Market Share by Country (2016-2027) Figure 24. United States Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Canada Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Europe Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. Europe Influenza Diagnostics Market Share by Type (2016-2027) Figure 28. Europe Influenza Diagnostics Market Share by Application (2016-2027) Figure 29. Europe Influenza Diagnostics Market Share by Country (2016-2027) Figure 30. Germany Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. France Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. U.K. Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Italy Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Russia Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Nordic Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Asia-Pacific Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Asia-Pacific Influenza Diagnostics Market Share by Type (2016-2027) Figure 38. Asia-Pacific Influenza Diagnostics Market Share by Application (2016-2027) Figure 39. Asia-Pacific Influenza Diagnostics Market Share by Region (2016-2027) Figure 40. China Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Japan Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. South Korea Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Southeast Asia Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. India Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Australia Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Latin America Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Latin America Influenza Diagnostics Market Share by Type (2016-2027) Figure 48. Latin America Influenza Diagnostics Market Share by Application (2016-2027) Figure 49. Latin America Influenza Diagnostics Market Share by Country (2016-2027) Figure 50. Mexico Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Brazil Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Middle East & Africa Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Middle East & Africa Influenza Diagnostics Market Share by Type (2016-2027) Figure 54. Middle East & Africa Influenza Diagnostics Market Share by Application (2016-2027) Figure 55. Middle East & Africa Influenza Diagnostics Market Share by Country (2016-2027) Figure 56. Turkey Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Saudi Arabia Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. UAE Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. BD Revenue Growth Rate in Influenza Diagnostics Business (2016-2021) Figure 60. Abbott (Include Alere) Revenue Growth Rate in Influenza Diagnostics Business (2016-2021) Figure 61. Roche Revenue Growth Rate in Influenza Diagnostics Business (2016-2021) Figure 62. SIEMENS Revenue Growth Rate in Influenza Diagnostics Business (2016-2021) Figure 63. Analytik Jena Revenue Growth Rate in Influenza Diagnostics Business (2016-2021) Figure 64. Quidel Revenue Growth Rate in Influenza Diagnostics Business (2016-2021) Figure 65. Thermo Fisher Revenue Growth Rate in Influenza Diagnostics Business (2016-2021) Figure 66. Meridian Bioscience Revenue Growth Rate in Influenza Diagnostics Business (2016-2021) Figure 67. BioMerieux Revenue Growth Rate in Influenza Diagnostics Business (2016-2021) Figure 68. Sekisui Diagnostics Revenue Growth Rate in Influenza Diagnostics Business (2016-2021) Figure 69. Response Biomedical Revenue Growth Rate in Influenza Diagnostics Business (2016-2021) Figure 70. SA Scientific Revenue Growth Rate in Influenza Diagnostics Business (2016-2021) Figure 71. Bottom-up and Top-down Approaches for This Report Figure 72. Data Triangulation Figure 73. Key Executives Interviewed

BD Abbott (Include Alere) Roche SIEMENS Analytik Jena Quidel Thermo Fisher Meridian Bioscience BioMerieux Sekisui Diagnostics Response Biomedical SA Scientific